Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol/Diclofenac FDC for Acute Pain After Third Molar Extraction
NCT03714672Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Aug 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tramadol and diclofenac in acute pain (4 arms), sponsored by Grünenthal GmbH. Primary endpoint: Total Pain Relief Over the 4 Hours Post-dose. Started Aug 2017; status: completed.
02
Drugs
tramadoldiclofenac
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03714672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03714672.